cancer Flashcards
risk factors
smoking asbestos nickel chromates radiation atmospheric pollution genetics
clinical presentation local effects
obstruction of airways - pneumonia
invasion of chest wall - pain
ulceration - haemoptysis
clinical presentation metastases
nodes
bones
liver
brain
clinical presentation systemic effects
weight loss
ectopic hormone production
PTH - squamous cancer
ACTH - small cell cancer
respiratory acinus
functional unit of the lung
extends through respiratory bronchiole, alveolar ducts and alveoli
classification
adenocarcinoma - 35% squamous carcinoma - 30% small cell carcinoma - 25% large cell carcinoma - 10% neuroendocrine bronchal gland
why classify
prognosis
treatment
pathogenesis/biopsy
epidemiology
survival time
small cell worst
large cell worse than squamous or adenocarcinoma
immunohistochemistry adenocarcinoma
expresses TTF - thyroid transcription factor
immunohistochemistry squamous carcinoma
expresses nuclear antigen p63 and high molecular weight cytokeratins
EFGR
oncogene
erlotinib
tyrosine kinase inhibitors
EGFR tumours respond
crizotinib
EML4-ALK fusion oncogene also identifies a target for specific drug treatment
pathogenesis
pulmonary epithelium
bronchial - ciliated, mucous, neuroendocrine, reserve
bronchioles/alveoli - club cells, types 1 and 2 alveolar cells
bronchial large airway tumours
squamous metaplasia
dysplasia
carcinoma in situ
invasive malignancy
peripheral adenocarcinomas
atypical adenomatous hyperplasia
spread of neoplastic cells along alveolar walls
true invasive adenocarcinoma
carcinoid
neuroendocrine neoplasms of low grade malignancy
bronchial gland neoplasms
often seen in salivary glands
adenoid cystic carcinoma
mucoepidermoid carcinoma
treatment options
giving the diagnosis surgery radiotherapy chemotherapy supportive care
small cell
rapidly progressive disease
early metastases
rarely suitable for surgery
good initial response to chemotherapy
non small cell
includes squamous and adeno carcinoma
curative options are surgery or radical radiotherapy
palliative chemotherapy and new targeted treatment
majority of lung cancers
surgery for lung cancer
pneumonectomy or lobectomy
curative objective
peri-operative mortality
post-operative morbidity
cytotoxic chemotherapy
rarely curative but longer survival better response in small cell cancer major side effects IV every 3-4 weeks outpatient visits targets rapidly dividing cells
chemotherapy side effects
nausea and vomiting tiredness bone marrow suppression hair loss pulmonary fibrosis